vs

Side-by-side financial comparison of Duolingo, Inc. (DUOL) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.

P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $295.5M, roughly 1.3× Duolingo, Inc.). Duolingo, Inc. runs the higher net margin — 11.9% vs -19.6%, a 31.5% gap on every dollar of revenue. On growth, Duolingo, Inc. posted the faster year-over-year revenue change (27.0% vs 3.8%). Over the past eight quarters, Duolingo, Inc.'s revenue compounded faster (28.7% CAGR vs -0.5%).

Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

DUOL vs PIII — Head-to-Head

Bigger by revenue
PIII
PIII
1.3× larger
PIII
$384.8M
$295.5M
DUOL
Growing faster (revenue YoY)
DUOL
DUOL
+23.2% gap
DUOL
27.0%
3.8%
PIII
Higher net margin
DUOL
DUOL
31.5% more per $
DUOL
11.9%
-19.6%
PIII
Faster 2-yr revenue CAGR
DUOL
DUOL
Annualised
DUOL
28.7%
-0.5%
PIII

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DUOL
DUOL
PIII
PIII
Revenue
$295.5M
$384.8M
Net Profit
$35.1M
$-75.5M
Gross Margin
55.5%
Operating Margin
8.0%
-40.0%
Net Margin
11.9%
-19.6%
Revenue YoY
27.0%
3.8%
Net Profit YoY
24.0%
-28.8%
EPS (diluted)
$0.72
$-23.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DUOL
DUOL
PIII
PIII
Q1 26
$295.5M
Q4 25
$282.9M
$384.8M
Q3 25
$271.7M
$345.3M
Q2 25
$252.3M
$355.8M
Q1 25
$230.7M
$373.2M
Q4 24
$209.6M
$370.7M
Q3 24
$192.6M
$362.1M
Q2 24
$178.3M
$379.2M
Net Profit
DUOL
DUOL
PIII
PIII
Q1 26
$35.1M
Q4 25
$42.0M
$-75.5M
Q3 25
$292.2M
$-31.6M
Q2 25
$44.8M
$-20.4M
Q1 25
$35.1M
$-20.5M
Q4 24
$13.9M
$-58.6M
Q3 24
$23.4M
$-46.5M
Q2 24
$24.4M
$-12.0M
Gross Margin
DUOL
DUOL
PIII
PIII
Q1 26
55.5%
Q4 25
72.8%
Q3 25
72.5%
Q2 25
72.4%
Q1 25
71.1%
Q4 24
71.9%
Q3 24
72.9%
Q2 24
73.4%
Operating Margin
DUOL
DUOL
PIII
PIII
Q1 26
8.0%
Q4 25
15.4%
-40.0%
Q3 25
12.9%
-12.8%
Q2 25
13.2%
-9.6%
Q1 25
10.2%
-10.2%
Q4 24
6.6%
-37.4%
Q3 24
7.0%
-29.5%
Q2 24
10.5%
-8.3%
Net Margin
DUOL
DUOL
PIII
PIII
Q1 26
11.9%
Q4 25
14.8%
-19.6%
Q3 25
107.5%
-9.1%
Q2 25
17.8%
-5.7%
Q1 25
15.2%
-5.5%
Q4 24
6.6%
-15.8%
Q3 24
12.1%
-12.8%
Q2 24
13.7%
-3.2%
EPS (diluted)
DUOL
DUOL
PIII
PIII
Q1 26
$0.72
Q4 25
$0.99
$-23.08
Q3 25
$5.95
$-9.67
Q2 25
$0.91
$-6.23
Q1 25
$0.72
$-6.28
Q4 24
$0.31
$-23.13
Q3 24
$0.49
$-15.70
Q2 24
$0.51
$-7.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DUOL
DUOL
PIII
PIII
Cash + ST InvestmentsLiquidity on hand
$1.1B
$25.0M
Total DebtLower is stronger
$228.4M
Stockholders' EquityBook value
$1.3B
$-155.2M
Total Assets
$2.0B
$656.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DUOL
DUOL
PIII
PIII
Q1 26
$1.1B
Q4 25
$1.0B
$25.0M
Q3 25
$1.0B
$37.7M
Q2 25
$976.2M
$38.6M
Q1 25
$884.0M
$40.1M
Q4 24
$785.8M
$38.8M
Q3 24
$854.4M
$63.0M
Q2 24
$888.2M
$73.1M
Total Debt
DUOL
DUOL
PIII
PIII
Q1 26
Q4 25
$228.4M
Q3 25
$252.8M
Q2 25
$182.0M
Q1 25
$171.1M
Q4 24
$108.9M
Q3 24
$133.2M
Q2 24
$133.1M
Stockholders' Equity
DUOL
DUOL
PIII
PIII
Q1 26
$1.3B
Q4 25
$1.3B
$-155.2M
Q3 25
$1.3B
$-18.7M
Q2 25
$977.0M
$44.5M
Q1 25
$893.8M
$63.3M
Q4 24
$824.5M
$75.9M
Q3 24
$822.5M
$120.5M
Q2 24
$766.9M
$166.8M
Total Assets
DUOL
DUOL
PIII
PIII
Q1 26
$2.0B
Q4 25
$2.0B
$656.6M
Q3 25
$1.9B
$683.6M
Q2 25
$1.5B
$731.6M
Q1 25
$1.4B
$783.9M
Q4 24
$1.3B
$783.4M
Q3 24
$1.2B
$833.3M
Q2 24
$1.1B
$892.8M
Debt / Equity
DUOL
DUOL
PIII
PIII
Q1 26
Q4 25
Q3 25
Q2 25
4.09×
Q1 25
2.71×
Q4 24
1.43×
Q3 24
1.11×
Q2 24
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DUOL
DUOL
PIII
PIII
Operating Cash FlowLast quarter
$105.6M
$-25.7M
Free Cash FlowOCF − Capex
$103.0M
FCF MarginFCF / Revenue
34.9%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.01×
TTM Free Cash FlowTrailing 4 quarters
$368.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DUOL
DUOL
PIII
PIII
Q1 26
$105.6M
Q4 25
$107.3M
$-25.7M
Q3 25
$84.2M
$-15.4M
Q2 25
$90.7M
$-16.6M
Q1 25
$105.6M
$-33.5M
Q4 24
$83.3M
$-57.2M
Q3 24
$56.3M
$-22.6M
Q2 24
$62.4M
$-10.2M
Free Cash Flow
DUOL
DUOL
PIII
PIII
Q1 26
$103.0M
Q4 25
$96.6M
Q3 25
$79.4M
Q2 25
$89.5M
Q1 25
$104.3M
Q4 24
$81.4M
Q3 24
$53.1M
Q2 24
$56.8M
FCF Margin
DUOL
DUOL
PIII
PIII
Q1 26
34.9%
Q4 25
34.1%
Q3 25
29.2%
Q2 25
35.5%
Q1 25
45.2%
Q4 24
38.8%
Q3 24
27.6%
Q2 24
31.9%
Capex Intensity
DUOL
DUOL
PIII
PIII
Q1 26
Q4 25
3.8%
Q3 25
1.8%
Q2 25
0.5%
Q1 25
0.6%
Q4 24
0.9%
0.0%
Q3 24
1.7%
0.0%
Q2 24
3.1%
0.0%
Cash Conversion
DUOL
DUOL
PIII
PIII
Q1 26
3.01×
Q4 25
2.56×
Q3 25
0.29×
Q2 25
2.02×
Q1 25
3.01×
Q4 24
5.99×
Q3 24
2.41×
Q2 24
2.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DUOL
DUOL

Bookings$283.5M96%
Other$12.0M4%

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

Related Comparisons